You just read:

KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia

News provided by

KaloBios Pharmaceuticals, Inc.

Jul 29, 2015, 01:00 ET